That ship has sailed and the company barely pays taxes as is. Grew too quick too fast and it caught up with them. Thanks to the new CEO, CFO and board changes they might get a handle on the rampant management ineffectiveness. Takeover seems likely given that DB is now leading.
Great Synageva takeover strategy. LOL. That needs an investigation in itself. GEVA couldn't find patients before the purchase...how did Alexion expect to find more after the takeover?
Alexion's chance to write down the entire synageva asset and blame prior executives. Which is honest and true. Cleaning out the failed assts makes Alexion more of a target.
Hard to believe that any big Pharma will pay 40B or even 35B, as long as the share doesn't go below 100$ we are safe.
Assuming analyst know better, credit suisse and others are saying over $200 for a takeout price and worth it based on current assets...even better when company is lean and packaged for a sale.
Glad I left this company. There is so much fraud and incompetence! They even get paid on patients that already died but they keep them counted as patients on therapy still because nobody ever checks to see if a patient really exists.
Now with Ludwig hantson as CEO all will be well. For him. He did so well at Baxalta. Cashing million for being CEO less than a year and handing us over to be acquired by shire. Congratulations to that folks at alexion
Sorry, million was a typo. Baxalta President and CEO Ludwig Hantson received almost $19 million in 2015 for running a company that was not even a year old.
